Literature DB >> 4216389

Studies on whole-body potassium in non-ketoacidotic diabetics before and after treatment.

C H Walsh, N G Soler, H James, M G Fitzgerald, J M Malins.   

Abstract

Serial measurements of whole-body potassium were carried out in 28 diabetic patients, in 23 of whom diabetes had only recently been diagnosed. Eleven patients were treated with insulin, 12 with oral hypoglycaemic agents, and the rest were already on oral hypoglycaemic agents and had developed poor diabetic control; four of these required insulin. Whole-body potassium was measured before treatment was begun (or altered) and again one and six weeks later. Whole-body potassium (ratio of observed to expected) was initially reduced in most of the patients requiring insulin. After control of diabetes whole-body potassium increased significantly in the three groups. The increase in whole-body potassium in the individual patients varied over a wide range, and in patients who were treated with insulin it was often of a similar magnitude to that observed in patients in diabetic ketoacidosis.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4216389      PMCID: PMC1612802          DOI: 10.1136/bmj.4.5947.738

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  9 in total

1.  The measurement of total body fat with skinfold calipers.

Authors:  R F FLETCHER
Journal:  Clin Sci       Date:  1962-06       Impact factor: 6.124

2.  Isotopic studies of potassium metabolism in diabetes.

Authors:  J K AIKAWA; J H FELTS; G T HARRELL
Journal:  J Clin Invest       Date:  1953-01       Impact factor: 14.808

3.  STUDIES IN DIABETIC ACIDOSIS AND COMA, WITH PARTICULAR EMPHASIS ON THE RETENTION OF ADMINISTERED POTASSIUM.

Authors:  T S Danowski; J H Peters; J C Rathbun; J M Quashnock; L Greenman
Journal:  J Clin Invest       Date:  1949-01       Impact factor: 14.808

4.  Metabolic studies in severe diabetic ketosis.

Authors:  J D N NABARRO; A G SPENCER; J M STOWERS
Journal:  Q J Med       Date:  1952-04

5.  Potassium balance during treatment of diabetic ketoacidosis with special reference to the use of bicarbonate.

Authors:  N G Soler; M A Bennett; K Dixon; M G FitzGerald; J M Malins
Journal:  Lancet       Date:  1972-09-30       Impact factor: 79.321

Review 6.  Severe diabetic ketoacidosis (diabetic "coma"). 482 episodes in 257 patients; experience of three years.

Authors:  P M Beigelman
Journal:  Diabetes       Date:  1971-07       Impact factor: 9.461

7.  The calibration of a whole-body radioactivity counter for the measurement of body potassium content in clinical studies.

Authors:  D Hughes; R E Williams
Journal:  Clin Sci       Date:  1967-06       Impact factor: 6.124

8.  Exchangeable potassium in diabetics.

Authors:  N Telfer
Journal:  Metabolism       Date:  1966-06       Impact factor: 8.694

9.  Glucose intolerance with hypokalemia. Failure of short-term potassium depletion in normal subjects to reproduce the glucose and insulin abnormalities of clinical hypokalemia.

Authors:  P Gorden
Journal:  Diabetes       Date:  1973-07       Impact factor: 9.461

  9 in total
  5 in total

1.  Hyperaldosteronism in ketoacidosis and in poorly controlled non-ketotic diabetes.

Authors:  C Quigley; P A Sullivan; H Gonggrijp; M J Crowley; J B Ferriss; D J O'Sullivan
Journal:  Ir J Med Sci       Date:  1982-05       Impact factor: 1.568

2.  The application of potassium selective electrodes in the intensive care unit.

Authors:  T Treasure
Journal:  Intensive Care Med       Date:  1978-04       Impact factor: 17.440

3.  Potassium status of patients with cirrhosis.

Authors:  N G Soler; S Jain; H James; A Paton
Journal:  Gut       Date:  1976-02       Impact factor: 23.059

Review 4.  Non-insulin-dependent (type II) diabetes mellitus.

Authors:  W Rodger
Journal:  CMAJ       Date:  1991-12-15       Impact factor: 8.262

Review 5.  Review of Evidence for Adult Diabetic Ketoacidosis Management Protocols.

Authors:  Tara T T Tran; Anthony Pease; Anna J Wood; Jeffrey D Zajac; Johan Mårtensson; Rinaldo Bellomo; Elif I I Ekinci
Journal:  Front Endocrinol (Lausanne)       Date:  2017-06-13       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.